• Most Popular
  • Most Shared

Novo Nordisk's Victoza gets EU market green light

Fri Jul 3, 2009 5:04am EDT

Stocks

   

COPENHAGEN, July 3 (Reuters) - Danish pharmaceuticals group Novo Nordisk's (NOVOb.CO) diabetes treatment Victoza has won European Commission approval for marketing across the EU, the company said on Friday.

"The European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in adults," Novo Nordisk said in a statement, calling it an "important milestone."

The company will launch Victoza in the UK, Germany and Denmark this summer and in other European markets in the second half of 2009 and throughout 2010, it said.

"The marketing approval in Europe does not change Novo Nordisk's expectations for the company's financial results for 2009," it added.



More from Reuters

Photo

Bomber, U.S. drone attack in Pakistan

ISLAMABAD (Reuters) - A suicide bomber killed up to 10 people in Pakistan Friday, while a suspected U.S. drone killed six militants, as rising political tension threatened to distract the government from its war against the Taliban.

» More Top News
U.S. President Barack Obama attends the morning plenery session of the United Nations Climate Change Conference (COP15) at the Bella Center in Copenhagen, Denmark, December 18, 2009. REUTERS/Larry Downing

Time running out on climate

President Barack Obama met world leaders in Copenhagen in a bid to reach a new global climate agreement after all-night talks failed.   Full Article | Video 

Climate conference
Pedestrians are reflected in a Citigroup window in Boston, Massachusetts. REUTERS/Brian Snyder

Citi's next challenge

Citigroup's plan to extract itself from the government's clutches didn't go as planned. For the bank to succeed, one of two things need to happen.  Full Article 

ECONOMY